Tamara A. Favorito
CIK: 0001288232
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Jul 17, 2026ARTL
ARTELO BIOSCIENCES, INC.
Award(A)DirectStock Option (right to buy)
136 shares- - Jun 4, 2026ZVRA
ZEVRA THERAPEUTICS, INC.
Award(A)DirectStock Option (right to buy)
30K shares- - Jan 30, 2026ARTL
ARTELO BIOSCIENCES, INC.
Award(A)DirectStock Options (right to buy)
292 shares- - Oct 28, 2025ARTL
ARTELO BIOSCIENCES, INC.
Conversion(C)DirectConvertible Promissory Note
0 shares at avg. $25000.00- - Oct 28, 2025ARTL
ARTELO BIOSCIENCES, INC.
Conversion(C)DirectConvertible Promissory Note
0 shares at avg. $19793.00- - Oct 28, 2025ARTL
ARTELO BIOSCIENCES, INC.
Conversion(C)DirectWarrant (right to buy)
12.6K shares- - Oct 28, 2025ARTL
ARTELO BIOSCIENCES, INC.
Conversion(C)DirectWarrant (right to buy)
6.8K shares- - Sep 12, 2025ZVRA
ZEVRA THERAPEUTICS, INC.
Purchase(P)Direct3.2K shares at avg. $7.79$25K - May 29, 2025ZVRA
ZEVRA THERAPEUTICS, INC.
Award(A)DirectStock Option (right to buy)
30K shares- - May 1, 2025ARTL
ARTELO BIOSCIENCES, INC.
Purchase(P)IndirectConvertible Promissory Note
0 shares at avg. $25000.00- - Dec 20, 2024ARTL
ARTELO BIOSCIENCES, INC.
Award(A)DirectStock Option (right to buy)
1.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 17, 2026 |  ARTL ARTELO BIOSCIENCES, INC. | Award(A) Stock Option (right to buy) | 136 | - | - | Direct |
| Jun 4, 2026 |  ZVRA ZEVRA THERAPEUTICS, INC. | Award(A) Stock Option (right to buy) | 30,000 | - | - | Direct |
| Jan 30, 2026 | ARTL ARTELO BIOSCIENCES, INC. | Award(A) Stock Options (right to buy) | 292 | - | - | Direct |
| Oct 28, 2025 | ARTL ARTELO BIOSCIENCES, INC. | Conversion(C) Convertible Promissory Note | 0 | $25000.00 | - | Direct |
| Oct 28, 2025 | ARTL ARTELO BIOSCIENCES, INC. | Conversion(C) Convertible Promissory Note | 0 | $19793.00 | - | Direct |
| Oct 28, 2025 | ARTL ARTELO BIOSCIENCES, INC. | Conversion(C) Warrant (right to buy) | 12,566 | - | - | Direct |
| Oct 28, 2025 | ARTL ARTELO BIOSCIENCES, INC. | Conversion(C) Warrant (right to buy) | 6,846 | - | - | Direct |
| Sep 12, 2025 | ZVRA ZEVRA THERAPEUTICS, INC. | Purchase(P) | 3,175 | $7.79 | $24,718 | Direct |
| May 29, 2025 | ZVRA ZEVRA THERAPEUTICS, INC. | Award(A) Stock Option (right to buy) | 30,000 | - | - | Direct |
| May 1, 2025 | ARTL ARTELO BIOSCIENCES, INC. | Purchase(P) Convertible Promissory Note | 0 | $25000.00 | - | Indirect |
| Dec 20, 2024 | ARTL ARTELO BIOSCIENCES, INC. | Award(A) Stock Option (right to buy) | 1,750 | - | - | Direct |
1-11 of 11 transactions
About FAVORITO TAMARA A
FAVORITO TAMARA A (SEC CIK 0001288232) files insider reports with the SEC as Director of ARTELO BIOSCIENCES, INC. (ARTL) and Director of ZEVRA THERAPEUTICS, INC. (ZVRA).
Signal8 holds 8 ownership filings by FAVORITO TAMARA A, all Form 4s, filed between Dec 23, 2024 and Jul 21, 2026. Those filings report 11 transactions, from Dec 20, 2024 to Jul 17, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on FAVORITO TAMARA A's filings is in SOLANA BEACH, CA.
Recent filings by FAVORITO TAMARA A
- Jul 17, 2026: Grant or award of ARTL derivative securities (Form 4, code A).
- Jun 4, 2026: Grant or award of ZVRA derivative securities (Form 4, code A).
- Jan 30, 2026: Grant or award of ARTL derivative securities (Form 4, code A).
- Oct 28, 2025: Conversions of ARTL derivative securities (4 lines, Form 4, code C).
- Sep 12, 2025: Open-market purchase of ZVRA shares (Form 4, code P).
Other insiders filing for ARTELO BIOSCIENCES, INC. (ARTL)
- MATSUI CONNIE, Director
- Blayney Douglas, Director
- Reyes Gregory, Director
- EMANUELE ROBERT MARTIN, Director
- Kelly Steven, Director
- Spring Mark Edward, Chief Financial Officer